Loading clinical trials...

UNKNOWNNA

Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes

NCT04905485•Viome

Summary

Participants who were previously Viome costumers who signed informed consent to participate and self reported type 2 diabetes or pre-diabetes were enrolled. They provided stool samples to VIOME and were provided with precision diet and supplement recommendations. The information obtained from this study is used to train a model to predict diabetes and/or risks of developing diabetes.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Viome customer
•GI test collected at home using Viome test kit
•US citizen
•18+ years old
•Is not participating in any other Viome study
•Must have answered the following on-boarding question with the indicated answer:
•"Do you or did you ever have diabetes or prediabetes?"
•Signed and dated informed consent prior to any trial-specific procedures are performed
•Able to speak and read English
•Willing and able to follow the trial instructions

Exclusion Criteria

•Unable/unwilling to complete the informed consent form and the questionnaires

Locations (1)

Viome Research Institute

Bothell, Washington, United States

Key Dates

Start Date

May 21, 2021

Primary Completion Date

December 31, 2023

Completion Date

December 31, 2023

Last Updated

June 8, 2021

Enrollment

2,912

ACTUAL participants

Conditions

Diabetes Type 2DiabetesPre-diabetes

Interventions

VIOME Precision Nutrition Program

BEHAVIORAL

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

RECRUITING

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 8, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes

Inclusion Criteria

Exclusion Criteria

Feasibility of a Tailored Online Self-compassion Intervention

Genetic Studies of Insulin and Diabetes

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

iGlarLixi CGM Study in Chinese T2D Individuals After OADs

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes